iodinated contrast medium for x rays
CN → US| HS编码 | 关税税率 | 原产国 | 目的国 | 文档 |
|---|---|---|---|---|
| 3822190030 | 10.0% | CN | US | 官方文档 |
| 3822190080 | 10.0% | CN | US | 官方文档 |
| 3004901000 | 10.0% | CN | US | 官方文档 |
商品图片
AI分析
💉 Iodinated Contrast Medium for X-Rays (Medical Imaging Agents)
🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional通关 Strategy for Medical Diagnostics
📌 I. Product Definition & Classification: What Exactly is "Iodinated Contrast Medium"?
Iodinated contrast media are chemical agents used to enhance the contrast of structures within the body during medical imaging procedures, such as CT scans and angiography. In international trade, classification depends heavily on whether the product is viewed as a finished therapeutic/preparative drug or a chemical diagnostic reagent.
⚠️ Key Distinction Point:
- If the product is formulated as a sterile solution or powder intended for direct medical use (administration to patients) → It falls under Chapter 30 (Pharmaceutical Products).
- If the product is a raw chemical compound or non-sterile diagnostic reagent used in laboratory settings or as an intermediate → It falls under Chapter 38 (Miscellaneous Chemical Products).
📦 II. HS Code Classification Details (2026 Latest Tariff Authority Cross-Reference)
| HS Code | Product Description | Application Scenario | Classification Basis |
|---|---|---|---|
3004.90.10.00 |
Medicaments (including veterinary) consisting of mixed or unmixed products for therapeutic or prophylactic uses | Final medical grade contrast agents: Sterile solutions or powders ready for clinical injection or ingestion. | Fits the "Residual Category" principle for therapeutic/preventive medicines. |
3822.19.00.80 |
Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents, whether or not on a backing | Chemical diagnostic reagents: Iodine-based compounds used for diagnostic purposes in labs or as non-sterile diagnostic aids. | Fits the definition of "diagnostic or laboratory reagents of a chemical nature." |
3822.19.00.30 |
Prepared diagnostic or laboratory reagents (other than goods of heading 30.02 or 30.06) | Antigen/Antibody/Chemical Reagents: Iodinated compounds classified under specific chemical reagent attributes (e.g., containing antigens/antiserum equivalents in a diagnostic context). | Fits the attribute of chemical reagents containing antigens or antiserum properties. |
🔍 Critical Reminder:
- Finished Medical Devices/Drugs: If the contrast medium is sterile, packaged for single use, and intended for human administration, it MUST be classified under3004.90.10.00.
- Raw/Intermediate/Non-Sterile: If it is a bulk chemical, non-sterile powder, or a reagent for in-vitro lab analysis (not for injection), it may fall under3822.19.00.80or3822.19.00.30.
💰 III. 2026 Latest Tariff Rate Details (Including Surtaxes & Policy Add-ons)
✅ Applicable Country: United States (US)
✅ Country of Origin: China (CN)
✅ Effective Date: From November 10, 2025 (including subsequent imports)
🎯 1. 3004.90.10.00 —— Therapeutic/Prophylactic Medicaments (Contrast Agents)
| Item | Content |
|---|---|
| Base Tariff Rate | 0% (ad valorem) |
| USITC Surtax | 0% |
| Section 122 Surtax | +10% |
| Total Tariff Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Exemption | ❌ Not Eligible |
| Legal Basis Path | Section 122: 10% applied to pharmaceutical imports from China. |
📌 Explanation:
- The Base Tariff for many pharmaceuticals is 0%.
- The 10% Surtax is applied under Section 122 (or related trade enforcement mechanisms active in 2025/2026 for specific Chinese-origin medical chemicals/drugs).
- Total Cost Impact: A $10,000 shipment incurs $1,000 in duties.
🎯 2. 3822.19.00.80 —— Diagnostic/Laboratory Reagents (Chemical Nature)
| Item | Content |
|---|---|
| Base Tariff Rate | 0% (ad valorem) |
| USITC Surtax | 0% |
| Section 122 Surtax | +10% |
| Total Tariff Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Exemption | ❌ Not Eligible |
| Legal Basis Path | Section 122: 10% applied to chemical diagnostic reagents from China. |
📌 Explanation:
- Despite being a "chemical reagent," the Section 122 surcharge applies uniformly to these goods from China.
- Total Cost Impact: A $10,000 shipment incurs $1,000 in duties.
🎯 3. 3822.19.00.30 —— Prepared Diagnostic Reagents (Antigen/Antiserum Attributes)
| Item | Content |
|---|---|
| Base Tariff Rate | 0% (ad valorem) |
| USITC Surtax | 0% |
| Section 122 Surtax | +10% |
| Total Tariff Rate | 10.0% |
| Tax Calculation | CIF Value × 10% |
| De Minimis Exemption | ❌ Not Eligible |
| Legal Basis Path | Section 122: 10% applied to specific chemical reagents from China. |
📌 Explanation:
- This code is for reagents with specific antigen/antiserum-like properties.
- Total Cost Impact: A $10,000 shipment incurs $1,000 in duties.Note: All three HS codes listed in the provided data have an identical 10% total tariff rate due to the Section 122 surcharge, despite having different base classifications. The difference lies in regulatory compliance (FDA vs. Lab Chemical regulations), not just duty cost.
🛠️ IV. Customs Clearance Operational Advice (Practical Pitfall Avoidance Guide)
✅ 1. Required Documentation Checklist (All are Mandatory)
| Document | Must Provide | Description |
|---|---|---|
| ✅ Product Specification Sheet | ✔️ | Must state: Iodine concentration (e.g., 300 mgI/mL), sterility status, pH, osmolality. |
| ✅ Certificate of Analysis (CoA) | ✔️ | Proves chemical purity and diagnostic/therapeutic efficacy. |
| ✅ FDA Registration/Listing Number | ✔️ | Critical for Chapter 30 (Drugs) or Chapter 38 (Reagents) clearance. |
| ✅ Sterility Certification | ✔️ | If classifying under 3004, proof of sterile manufacturing is mandatory. |
| ✅ Commercial Invoice | ✔️ | Must clearly describe the product as "Iodinated Contrast Medium for Medical Imaging" or "Diagnostic Reagent." |
| ✅ Packing List | ✔️ | Details packaging (vials, boxes) and net/gross weight. |
| ✅ Country of Origin Certificate | ✔️ | To prove origin from China (triggering the 10% surcharge). |
✅ 2. Declaration Strategies (Key Mnemonics)
🔥 "Sterile for Injection = Drug (3004); Non-Sterile/Lab Use = Reagent (3822)"
| Scenario | Correct Declaration | Wrong Practice |
|---|---|---|
| Injectable CT Contrast Agent (Sterile, Patient-Ready) | 3004.90.10.00"Therapeutic Pharmaceutical Product" |
Declaring as a "Chemical Reagent" → FDA Reject/Seizure Risk |
| Non-Sterile Iodine Solution (For Lab Use Only) | 3822.19.00.80"Diagnostic Laboratory Reagent" |
Declaring as "Medicine" → Regulatory Mismatch |
| Raw Iodine Compound (Intermediate) | 3822.19.00.30"Chemical Reagent with Antigen Properties" |
Declaring as "Finished Drug" → Compliance Violation |
📌 Critical Warning:
- Misclassifying a medical drug as a lab reagent to avoid stricter drug regulations is a serious violation.
- The 10% tariff is the same for all three codes in the provided data, so compliance with FDA/chemical safety regulations is the primary decision factor, not tax savings.
✅ 3. Special Case Handling
| Situation | Handling Advice |
|---|---|
| OEM Contract Manufacturing | Provide the contract between the manufacturer and the US brand owner. Ensure the US importer holds the FDA license. |
| Mixed Shipments (Drugs + Reagents) | Do NOT mix in one HS Code. Declare separately to avoid FDA holds. |
| Small Samples for Clinical Trials | Even small quantities require FDA prior notice and correct HS Code. Do not use De Minimis exemptions. |
| Temperature-Sensitive Goods | Specify "Keep Refrigerated" on the invoice. Failure to do so may lead to product rejection, regardless of HS Code. |
🌍 V. Global Market Comparison (2026 Latest)
| Country/Region | Recommended HS Code | Tariff (China Origin) | Certification Requirements | Remarks |
|---|---|---|---|---|
| 🇺🇸 USA | 3004.90.10.00 (Drug) |
10% (10% Section 122) | FDA Listing + Establishment Registration | Strict sterile requirements. |
| 🇺🇸 USA | 3822.19.00.80 (Reagent) |
10% (10% Section 122) | EPA/State Lab Chemical Regulations | For in-vitro use only. |
| 🇪🇺 EU | 3004.90.10.00 |
0% (if GSP/EPA applies) | CE Mark + EUDAMED | Complex regulatory approval process. |
| 🇨🇳 China | 3004.90.10.00 |
Varies (usually low) | NMPA Approval | Import requires Chinese drug license. |
📌 Conclusion:
- USA Tariff Impact: The 10% Section 122 surcharge is significant. Since the base rate is 0%, this 10% represents the entire duty burden for these goods from China.
- Regulatory Priority: In the US, FDA approval is far more critical than the 10% tariff. Misclassification can lead to goods being destroyed.
📌 VI. Common Errors & Pitfall Guide (Lessons Learned)
❌ Error 1: Declaring Injectable Contrast Media as "Lab Reagent" (3822)
👉 Consequence: FDA seizure, product destruction, and potential legal action.
👉 Correct: Must declare as 3004.90.10.00 with FDA drug listing.
❌ Error 2: Ignoring the "Sterile" Status in Description
👉 Consequence: Customs may question the medical use claim.
👉 Correct: Explicitly state "Sterile Solution for Medical Imaging" or "Non-Sterile Laboratory Reagent."
❌ Error 3: Assuming De Minimis Exemption Applies
👉 Consequence: DENIED. Medical/chemical goods from China under Section 122 are not eligible for de minimis.
👉 Correct: File entry even for small samples.
❌ Error 4: Incorrectly Applying "Free" Base Rate as Total Cost
👉 Consequence: Underpaying duties. The 0% base rate is misleading.
👉 Correct: Always calculate Base Rate (0%) + Section 122 (10%) = 10% Total.
✅ Correct Declaration Example:
"Iodinated Contrast Medium for X-Ray, Sterile Solution, 300mgI/mL, 50mL Vials, for Medical Diagnostic Use Only. FDA Listed. HS Code: 3004.90.10.00. Origin: China. Subject to 10% Section 122 Surtax."
🎯 VII. Conclusion: Professional Declaration, Cost & Compliance Optimization!
🎯 Remember the Mantras:
🔹 "Sterile = Drug (3004); Non-Sterile = Reagent (3822)"
🔹 "0% Base + 10% Section 122 = 10% Total Duty"
🔹 "FDA Compliance > Tariff Savings. Misclassification = Seizure!"
📌 Pro Tip:
If you are importing non-sterile iodine compounds for industrial or non-medical purposes, ensure your supplier provides a Letter of Intent stating "Not for Human Use" to support classification under
3822.
For medical use, prioritize FDA compliance over minor regulatory ambiguities.
📣 Immediate Action:
📞 Contact your customs broker to verify FDA entry status.
🚀 Ensure precise classification to avoid costly delays and seizures!
✨ Professional Clearance Starts with Accurate Classification!
💼 Your cost structure depends on it!
用户评价
关于 HS 编码归类
协调制度(HS)是由世界海关组织(WCO)制定的国际贸易商品分类标准。全球 200 多个国家采用 HS 系统作为海关关税、贸易统计和进出口监管的基础。
每个 HS 编码遵循以下层级结构:
- 章(2 位)——商品大类(例如:第 84 章:机器和机械设备)
- 品目(4 位)——章内的更具体分类
- 子目(6 位)——国际通用细分,所有 WCO 成员国统一使用
- 本国细分(8-10 位)——各国自行扩展的细分编码,如美国 HTSUS 10 位编码
正确的 HS 编码归类对于顺利通关、准确缴纳关税和遵守贸易法规至关重要。错误归类可能导致海关延误、多缴关税或罚款。
从CN进口到US时,适用的关税税率可能包括:
- 最惠国(MFN)税率——适用于 WTO 成员国的标准关税税率
- 普通税率——适用于无贸易协定国家
- 贸易救济关税——附加关税,如 301 条款(反倾销)、232 条款(国家安全)或反补贴税
本页内容仅供参考。如需正式归类,请咨询当地海关或持牌报关代理。